Search details
1.
Targeting the DNA damage response for cancer therapy.
Biochem Soc Trans
; 51(1): 207-221, 2023 02 27.
Article
in English
| MEDLINE | ID: mdl-36606678
2.
DNA damage checkpoint kinases in cancer.
Expert Rev Mol Med
; 22: e2, 2020 06 08.
Article
in English
| MEDLINE | ID: mdl-32508294
3.
Warburg and Krebs and related effects in cancer.
Expert Rev Mol Med
; 21: e4, 2019 09 27.
Article
in English
| MEDLINE | ID: mdl-31558177
4.
25 years of ERMM.
Expert Rev Mol Med
; 25: e12, 2023 04 18.
Article
in English
| MEDLINE | ID: mdl-37069821
5.
PARP inhibitor rucaparib induces changes in NAD levels in cells and liver tissues as assessed by MRS.
NMR Biomed
; 30(9)2017 Sep.
Article
in English
| MEDLINE | ID: mdl-28543772
6.
Not your model minority: Own-group activism among Asian Americans.
Cultur Divers Ethnic Minor Psychol
; 23(4): 499-507, 2017 Oct.
Article
in English
| MEDLINE | ID: mdl-28263621
7.
High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers.
Int J Cancer
; 138(1): 206-16, 2016 Jan 01.
Article
in English
| MEDLINE | ID: mdl-26178530
8.
Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer.
Br J Cancer
; 114(7): 723-30, 2016 Mar 29.
Article
in English
| MEDLINE | ID: mdl-27002934
9.
Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?
J Hepatol
; 65(2): 305-13, 2016 08.
Article
in English
| MEDLINE | ID: mdl-27132171
10.
Poly(ADP-Ribose) Polymerase in Cervical Cancer Pathogenesis: Mechanism and Potential Role for PARP Inhibitors.
Int J Gynecol Cancer
; 26(4): 763-9, 2016 May.
Article
in English
| MEDLINE | ID: mdl-26905326
11.
Advanced Ovarian Cancer Displays Functional Intratumor Heterogeneity That Correlates to Ex Vivo Drug Sensitivity.
Int J Gynecol Cancer
; 26(6): 1004-11, 2016 07.
Article
in English
| MEDLINE | ID: mdl-27327149
12.
The differential impact of discrimination on health among Black and White women.
Soc Sci Res
; 57: 99-115, 2016 May.
Article
in English
| MEDLINE | ID: mdl-26973034
13.
DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin.
Breast Cancer Res Treat
; 143(1): 47-55, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-24292814
14.
Poly(ADP-ribose) polymerase inhibitors in Ewing sarcoma.
Curr Opin Oncol
; 26(4): 428-33, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24840521
15.
PARP inhibitors for anticancer therapy.
Biochem Soc Trans
; 42(1): 82-8, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24450632
16.
Visualization of a DNA-PK/PARP1 complex.
Nucleic Acids Res
; 40(9): 4168-77, 2012 May.
Article
in English
| MEDLINE | ID: mdl-22223246
17.
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.
Breast Cancer Res
; 15(5): R92, 2013 Oct 01.
Article
in English
| MEDLINE | ID: mdl-24286369
18.
Microsatellite instability induced mutations in DNA repair genes CtIP and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase inhibitors in myeloid malignancies.
Haematologica
; 98(9): 1397-406, 2013 Sep.
Article
in English
| MEDLINE | ID: mdl-23349304
19.
Poly(ADP-ribose) polymerase-1 (PARP-1) pharmacogenetics, activity and expression analysis in cancer patients and healthy volunteers.
Biochem J
; 436(3): 671-9, 2011 Jun 15.
Article
in English
| MEDLINE | ID: mdl-21434873
20.
The Importance of Awareness, Acceptance, and Alignment With the Self: A Framework for Understanding Self-Connection.
Eur J Psychol
; 18(1): 120-131, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-35330854